Literature DB >> 9839692

The effect of interleukin-10 and transforming growth factor beta-1 on HLA-DR expression in colonic epithelial cells.

M J Zimmerman1, G R Radford-Smith, D P Jewell.   

Abstract

The aim of this study was to assess whether interleukin-10 (IL-10) and/or transforming growth factor beta-1 (TGFbeta1) downregulate HLA-DR expression using the HT29 cell line as a model of colonic epithelial cells. HLA-DR expression was induced in HT29 cells with gamma-interferon. The effects of IL-10 alone, TGFbeta1 alone, and IL-10 and TGFbeta1 in combination were studied. HLA-DR expression was assessed using flow cytometric analysis. Gamma-interferon induced HLA-DR expression in a dose-dependent fashion. In the absence of gamma-interferon, neither IL-10 nor TGFbeta1 induced HLA-DR expression. In isolation, neither IL-10 nor TGFbeta1 downregulated HLA-DR expression. When IL-10 and TGFbeta1 were added in combination, small (6-30%) statistically significant reductions in HLA-DR expression were seen. The biological significance is unclear.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9839692      PMCID: PMC1781823          DOI: 10.1080/09629359891315

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  31 in total

Review 1.  Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet.

Authors:  C Benoist; D Mathis
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

2.  Synergistic effect of IL-4 and IFN-gamma on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells.

Authors:  J O Phillips; M P Everson; Z Moldoveanu; C Lue; J Mestecky
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

Review 3.  MHC class II expression by the gut epithelium.

Authors:  P Bland
Journal:  Immunol Today       Date:  1988-06

4.  Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon.

Authors:  G B McDonald; D P Jewell
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

5.  Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells.

Authors:  J Péguet-Navarro; C Moulon; C Caux; C Dalbiez-Gauthier; J Banchereau; D Schmitt
Journal:  Eur J Immunol       Date:  1994-04       Impact factor: 5.532

6.  Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose.

Authors:  A Zweibaum; M Pinto; G Chevalier; E Dussaulx; N Triadou; B Lacroix; K Haffen; J L Brun; M Rousset
Journal:  J Cell Physiol       Date:  1985-01       Impact factor: 6.384

7.  Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression.

Authors:  B Crotty; P Hoang; H R Dalton; D P Jewell
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

8.  Evidence for function of Ia molecules on gut epithelial cells in man.

Authors:  L Mayer; R Shlien
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

9.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.